Spero Therapeutics, Inc. (SPRO) Insider Trading

Name: Spero Therapeutics, Inc. (SPRO) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Aug 6, 2026): Zack Debra (Chief Medical Officer): Grant/Award of 162,311 shares.

Get alerted when insiders trade SPRO

Email address

Loading company data...

Loading company details...